SCHEMBL9211000

SCHEMBL9211000

CCCCc1cn(C2C(C(C)C)CC2C(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)nc1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 15/20 0.58
AGTR2 P50052 13/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9208579 0.95 AGTR1 (0.60) AGTR1AGTR2
SCHEMBL9209906 0.94 AGTR1 (0.55) AGTR1AGTR2
SCHEMBL9206086 0.94 AGTR1 (0.60) AGTR1AGTR2
SCHEMBL9208421 0.94 AGTR1 (0.62) AGTR1AGTR2
SCHEMBL9276761 0.93 AGTR1 (0.55) AGTR1AGTR2
SCHEMBL9270894 0.92 AGTR1 (0.53) AGTR1AGTR2
SCHEMBL9274916 0.92 AGTR1 (0.58) AGTR1AGTR2
SCHEMBL9202209 0.91 AGTR1 (0.63) AGTR1AGTR2
SCHEMBL9271859 0.91 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9209621 0.91 AGTR1 (0.56) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0664803-A1 N-ARYLHETEROARYLALKYL 1-CYCLOALKYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1995-08-02 EP disclosed
WO-1994008989-A1 N-ARYLHETEROARYLALKYL 1-CYCLOALKYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1994-04-28 WO disclosed